We are pleased to announce that we launched T-TAS wS, a new addition to the T-TAS series, in certain areas of the European market on April 1, 2026. We have also renewed a dedicated product website.
T-TAS (Total Thrombus Formation Analysis System) is a device developed by ZACROS based on a proprietary measurement principle that quantitatively measures thrombus formation under blood flow conditions. T-TAS wS is an in vitro diagnostic medical device intended for professional use by healthcare professionals with dedicated chips in clinical laboratories.
Key features of T-TAS wS that differ from the earlier-generation model (T-TAS 01) include Laboratory Information System (LIS) connectivity, an integrated PC and monitor, and a built-in printer. These features are expected to improve usability—particularly in clinical applications—and enhance clinical value.
The chips and consumables used with T-TAS wS are identical to those used with T-TAS 01.
For more information, please visit the following websites:
・Product website : https://www.t-tas.info/index.html
■ For additional information
Corporate Communications Group, ZACROS Corporation
URL: https://www.zacros.co.jp/en/contact/